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What is already known about this subject? 
There is a strong association between high levels of cardio-respiratory fitness (CRF) and re-
duced risk of all-cause and cardiovascular mortality; these data mainly emanate from large 
North American databases. However, the associations of CRF with increasing age and 
changes in body composition with ageing have yet to be determined.   
 
What does this study add? 
In the largest study of its type in a UK population, we have shown that the prevalence of 
MetS is approximately one quarter of apparently healthy British men. Across increasing age-
strata (20 – 69 years), prevalence of MetS was 32 to 53% lower in those men with good CRF 
(“Fit”). The association between CRF and MetS is stronger in younger men and, while it 
weakens with age, the association remains independent of BMI for men aged <50 years. 
 
How might it impact on clinical practice in the near future?  
Public health messages should advocate the need for improving CRF alongside weight man-
agement for enhancing cardio-metabolic health. Inclusion of CRF assessments in UK health 
screening would provide greater insight into individualised metabolic health. 
 
 
 Abstract 
Background: Age and body mass index (BMI) are positively associated with the development 
of the metabolic syndrome (MetS). Cardiorespiratory fitness (CRF) can attenuate BMI-
related increases in prevalence of MetS, but the nature of this association across different 
age strata has not been fully investigated.  
Aim: To identify the association between CRF and MetS prevalence across age-strata (20– 
69 years) and determine whether associations are independent of BMI.  
Methods: CRF was estimated from incremental treadmill exercise in British men attending 
preventative health screening. Participants were placed in four age strata (20-39, 40-49, 50-
59 and 60-69 years) and classified as Fit or Unfit using age-related cut-offs. Presence of 
MetS was defined using the National Cholesterol Education Program Adult Treatment Panel 
III criteria.  
Results: 9 666 asymptomatic men (48.7±8.4 years) were enrolled. The prevalence of MetS 
was 25.5% in all men, and ranged from 17.1% in 20-39 year olds to 30.6% in 60-69 year olds. 
Fit men’s likelihood of meeting the criteria for MetS was half (OR=0.51, 95%CI:0.46-0.57) 
that of unfit men. The likelihood of MetS was 32-53% lower across age strata in Fit, com-
pared with Unfit men. Adjustment for BMI attenuated the association, though it remained 
significant in men aged 20-49 years.  
Conclusion: The cardio-metabolic benefits of CRF are independent of BMI particularly in 
men <50 years. Public health messages should emphasise the important role of CRF along-
side weight management for enhancing cardio-metabolic health. (250 words)  
 Introduction 
 
Adults with low cardiorespiratory fitness (CRF) have an increased risk of premature all-cause 
(70%) and cardiovascular mortality (56%) compared with the highest.1  Despite the potential 
value of exercise testing in health surveillance and preventive healthcare2, CRF is not rou-
tinely assessed in UK health surveys, nor employed in health screening. Screening relies on 
identifying the presence and clustering of traditional cardiovascular disease risk factors. 
These factors may indicate a pre-diabetic state, termed the metabolic syndrome (MetS). The 
health implications3, correlates4 and antecedents5 of MetS are well described elsewhere. In 
the UK, the ageing population continues to see rises in body mass index (BMI)6, which indi-
cates that prevalence of MetS may increase in years to come if left unchecked.  
 
The protection afforded by CRF occurs in a dose dependent fashion6. CRF can attenuate 
MetS risk7-10 but data describing CRF in UK adults are sparse11.The Aerobic Center Longitu-
dinal Study based at the Cooper Clinic is perhaps the largest source of data showing the 
cross-sectional relationship between CRF and cardio-metabolic risk12. Earnest and col-
leagues12 demonstrated that in 38,659 males and females, CRF demonstrated a strong in-
verse relationship with MetS after adjustment for BMI, smoking status, alcohol intake, and 
family history of cardiovascular disease. We aimed to determine the association between 
CRF and the prevalence of MetS across different age-strata of asymptomatic British men. 
These data are important as it is necessary to ascertain whether the strong inverse  
associations between CRF and MetS is maintained across the lifespan. We also attempted to 
determine the degree to which the association was independent from BMI.  
 Methods 
Ethical approval was granted by the Faculty of Society & Health ethics committee, Bucking-
hamshire New University. Participants (aged 20-69 years) attended one of five Health & 
Wellbeing clinics around the UK for a three-hour preventative health assessment between 
2000 and 2009. Participants attended general health examinations as an annual benefit 
provided by their corporate wellness schemes. Each participant was instructed in their pre-
assessment information pack to avoid any form of vigorous physical activity, alcohol and/or 
caffeinated beverages within the 24 hours prior to their assessment. Each participant signed 
and consented to the test battery and use of their data for research purposes.  
 
Anthropometric measurements 
Body mass was measured using digital scales (Marsden, UK) and recorded to the nearest 0.1 
kg. Clothing was worn but shoes and belts were removed, and participants evacuated their 
bladder before stepping onto the scales. Scales were calibrated daily with a known weight 
and bi-annually by the manufacturer. Stature was measured using a stadiometer (Seca, 
Hamburg, Germany) and recorded to the nearest 0.1 cm. Participants removed their shoes, 
stood on the stadiometer platform with feet together, and head in the Frankfort plane. But-
tocks and scapulae were in contact with the back of the stadiometer, shoulders relaxed with 
hands and arms loosely to the sides, the measurement was taken on full inhalation. Body 
mass index (BMI), was subsequently reported as kg∙m-2, then categorised into underweight 
(n=4, cases removed), normal weight (18.5-24.9 kg∙m-2), overweight (25-29.9 kg∙m-2), and 
obese (≥30 kg∙m-2)13. Waist circumference (WC) was measured using a standard anthropo-
metric flexible tape measure (Seca, Birmingham, UK), at minimal inspiration to the nearest 
0.1 cm, midway between the lowest rib and the iliac crest, which corresponded with the 
umbilical level in most participants.  
 
Venous blood sampling 
Participants presented in a fasted state (for the previous 12 hours) but ate a snack (fruit or 
muesli bar) prior to the exercise test. At the start of each assessment, fasted venous blood 
samples was obtained using vacutainer tubes and heparinised whole blood was analysed 
using the Piccolo blood chemistry analyser (Abaxis, USA). The following analytes were 
measured: glucose, total cholesterol (TC), low density lipoprotein (LDL), high density 
lipoprotein (HDL), triglycerides, and TC/HDL ratio. 
 
Exercise tolerance test 
Resting blood pressure was measured using a manual system (Accoson Duplex Aneroid 
Model, AC Cosser & Son Ltd, UK). Participants positioned themselves on the T2100 treadmill 
(GE Healthcare, UK), and undertook an incremental exercise test using the Bruce protocol. 
Blood pressure was monitored at the second minute of each stage using the automated 
Tango stress test monitor (Suntech Medical, Oxfordshire, UK). Rating of perceived exertion 
(RPE) was recorded at the end of each stage using the 6-20 Borg Scale. The electrocardio-
gram (ECG) was monitored throughout the test. Participants exercised until they attained 
≥85% of their age-predicted maximum heart rate determined by the 220-age formula, or 
met any of the ACSM  termination criteria. Peak oxygen uptake was estimated and reported 
in ml·kg-1·min-1 14. Data were categorised by 10-year age strata, and peak oxygen uptake 
(ml·kg-1·min-1) was classified as ‘Fit’ or ‘Unfit’ based on the Cooper Institute age- and sex-
specific cut-offs for CRF15 . 
 
Data treatment 
All participants with a diagnosis of cardio-metabolic disease were excluded from the analy-
sis. We defined the presence of Metabolic Syndrome (MetS) using the National Cholesterol 
Education Program Adult Treatment Panel III (NCEP ATP III) criteria16: Waist circumference 
>102 cm; serum triglycerides >1.7 mmol·l-1; HDL-cholesterol: <1.03 mmol·l-1; systolic blood 
pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg; fasting serum glucose >5.6 
mmol·l-1 or current treatment for diabetes. Each MetS component was classified as either 
present or absent according to the above criteria. We calculated the number of MetS com-
ponents present for each participant to provide an ordinal measure of cardio-metabolic 
health. Presence of ≥3 components was used to indicate presence of the MetS . 
 
Data Analysis 
SPSS version 22.0 (SPSS an IBM Company, IBM Ltd. NY, USA) was used to analyse the data. 
An alpha level of P<0.05 was accepted as significant. All variables were checked for normali-
ty using Kolmogorov-Smirnov tests. All continuous variables in Table 1 were normally dis-
tributed. Descriptive statistics were performed to identify means, standard deviations, and 
95% confidence intervals (CI). Area level deprivation was determined by home postal codes 
using the English Indices of Deprivation (EID) 17. A higher EID is indicative of a more deprived 
lower super output area. We compared socio-demographic and anthropometric values be-
tween participants classified as ‘Fit’ (versus ‘Unfit’) using independent t-tests for continuous 
variables and using χ 2 tests for categorical variables.   
We compared the prevalence of MetS components categorised as present across age 
groups using χ2 test and one-way analysis of variance (ANOVA). The number of MetS com-
ponents present between age-groups was analysed using the Kruskal-Wallace h-test. We 
used binary logistic regression analysis to determine the likelihood of a diagnosis of MetS 
within each age strata according to CRF. Using ‘Unfit’ as the referent category, we calculat-
ed the odds (OR; 95% CI) of presence of MetS within each age strata in participants classi-
fied as ‘Fit’. These estimates were adjusted for smoking status, area-level deprivation, and 
BMI. We also examined prevalence of MetS (%) based on a quintile distribution of CRF (Fig-
ure 1).   
 
Results 
9 666 asymptomatic men (48.7±8.4 years) were enrolled. Mean estimated peak oxygen up-
take, was 38.7 (±9.9) ml·kg-1·min-1 and 23.8% (n=2 401) of participants were classified as Un-
fit (Table 1). More than half, (54%) of the sample were overweight; and a further 18% were 
obese. Unfit men had significantly higher waist circumference, blood pressure, plasma tri-
glycerides, and lower levels of plasma HDL (all P<0.001). Fasting plasma glucose (P=0.075) 
and LDL (P=0.605) did not differ significantly according to CRF.   
 
Table 2 shows that 25.5% of all participants met the criteria for MetS, but prevalence varied 
by age group from 17.1% in those aged 20-39 years, to 30.6% in the 60-69-years category. 
When presenting prevalence (%) of MetS based on a quintile distribution of CRF (Figure 1), 
we noted an inverse linear association. MetS prevalence was 33.1% in the least fit group 
which reduced in a step-wise manner to the highest fit group (prevalence 16.5%, OR= 0.71 
[95% CI 0.61-0.83], P<0.001) after adjustment for age and BMI.  
 
Across all ages, the likelihood of MetS was significantly lower (OR=0.51, 95%CI:0.46-0.57) in 
Fit men. After adjusting for age, deprivation index, smoking status, and BMI; the likelihood 
of MetS in Fit men remained lower than those who were Unfit (OR=0.73; 95%CI:0.65-0.82; 
Table 3). Being classified as “Fit” significantly reduced the likelihood of MetS across the ma-
jority of age strata with or without additional adjustment for BMI. Applying Model 1 in men 
aged 60-69 years, being “Fit” was associated with a 32% lower odds of MetS (OR=0.68, 
95%CI:0.48-0.98; P=0.004), but when this estimate was corrected for BMI (Model 2), there 
was no longer a significant difference in the likelihood of MetS in this age strata (P=0.319).   
 
 
Discussion 
More than one-quarter (25.5%) of 9 666 asymptomatic males comprising our sample met 
the ATP III Criteria15 for presence of the metabolic syndrome (MetS) which is comparable 
with estimates (29-34%) from representative samples of US adult men.18 
The prevalence of MetS was higher than has been reported previously in UK adults. Brunner 
et al.4 reported that 11.7% of civil servants (age 30-63 years) surveyed between 1991 and 
1993 met their definition of MetS. Hyppönen et al.19 identified MetS in 9.7% of (n=6 810) 45 
year old men with a prevalence of overweight and obesity comparable to that of the pre-
sent study. Neither study included objective assessments of CRF or physical activity. 
Hyppönen et al.19 found self-reported physical activity was negatively associated with MetS, 
whereas Brunner et al.4 found no significant association. Neither of these large cohort stud-
ies examined the role of CRF. 
 
Cardiorespiratory Fitness and Metabolic Syndrome 
Fit men had significantly lower mean values for all MetS components (except glucose, 
P=0.075), fewer cardio-metabolic risk factors, and had a lower prevalence of MetS when 
compared with men classified Unfit. The association between CRF and MetS remained sig-
nificant when adjusting for BMI10. LaMonte et al.8 found MetS incidence was 53% lower in 
men within the highest tertile of CRF compared with the least fit. This estimate was not ad-
justed for BMI, but can be compared with our unadjusted estimate of 49%. Incidence of 
MetS in the oldest group (60-69 years), was nearly double that of the youngest participants 
(20-29 years), and there was a significant increase in each MetS component across age-
strata. Our findings are in agreement with studies describing an age-related increase in the 
prevalence of MetS20. To expand on previous findings we assessed whether the association 
between CRF and MetS differed according to age. The inverse association between higher 
levels of CRF and lower prevalence of MetS was most evident in younger men (54% lower 
likelihood) but persisted across all age groups, including those age 60-69 years (32%). Like 
MetS, the prevalence of obesity increased with age (Table 2). Adjusting for BMI attenuated 
the association between CRF and MetS but remained significant (33-34% lower) in men 
aged 20-49 years. The association was not statistically significant in 60-69 year-olds. Fit men 
of this age still had 16-17% lower risk of MetS than those who were less fit. These findings 
concur with previous studies that have used directly measured8 21 CRF. 
The MRC Ely Study examined the association between a continuous metabolic risk score, 
physical activity energy expenditure (PAEE), and CRF in healthy men (54 years)22. The ro-
bust, objective assessment of PAEE used was in contrast to the estimations of CRF from sub-
maximal exercise. Franks et al.23 showed that the association between a metabolic risk score 
and PAEE was three times stronger than what it shared with CRF. While Ekelund et al.22 
found a negative association between metabolic risk score and CRF, they reported that the 
association was no longer significant after adjusting for PAEE. The authors acknowledged 
the role of measurement error in their findings. Estimating CRF from sub-maximal exercise is 
associated with large random errors. Cycle ergometry may systematically underestimate 
CRF. Using data reported by the authors, we estimate that a healthy male, aged 54 years of 
age, would have a peak oxygen uptake of approximately 32 ±7 ml·kg-1·min-1.  This value is 
close to our Unfit group and below the normal range of values expected for men of this 
age15. 
Objectively measured CRF ‘outperforms’ physical activity24 and more-traditional cardiovas-
cular disease risk factors as an indicator of health7, and as a predictor of all-cause and cardi-
ovascular mortality20. These studies in conjunction with our findings provide further evi-
dence to support public health messages emphasising the importance of improving CRF for 
promoting cardio-metabolic health. Unlike US guidelines25, current UK messages largely fo-
cus on the promotion of physical activity per se, and in many cases, the relatively weak as-
sociation it shares with weight status and weight gain. 
The greatest risk of developing metabolic abnormalities, MetS, and CVD, is universally re-
ported in individuals with the lowest CRF values1 26. Relatively modest increases in physical 
activity in adults with initially low CRF can result in observable gains in CRF associated with 
reductions in morbidity and mortality9. Current guidelines for minimum physical activity 
levels in adults were established, in part, on the evidence of such gains in the least fit indi-
viduals.25  This is not to say that physical activity and BMI do not play an important role in 
metabolic health27 and cardiovascular disease21 28. Due, however, to the difficulties in meas-
uring physical activity and the modest reductions in BMI in response to physical activity, ob-
jectively measured CRF appears a more suitable outcome measure.  
Individuals with higher fitness levels are more likely to be involved in either, or in combina-
tion, a more habitually active lifestyle and/or participate in regular structured sporting activ-
ities. The umbrella term MetS is associated with oxidative stress, inflammation, and insulin 
resistance; it has been well established that exercise and increased physical activity are able 
to boost antioxidant capacity, and induce anti-inflammatory effects29. Exercise training posi-
tively regulates fat and glucose metabolism, and improves both blood pressure control and 
insulin action30. 
 
Limitations 
These data are drawn from an opportunistic sample of men attending private health screen-
ing at entry to a preventive health programme and may not be nationally representative 
sample. The mean area-level deprivation score for the sample was low, indicating partici-
pants lived in relatively affluent areas of the UK. MetS is positively associated with higher 
levels of deprivation, so the prevalence may be higher in a nationally representative sample. 
The fact that all participants were voluntarily participating in a preventive healthcare pro-
gramme may have biased the sample either towards health conscious individuals which 
would likely produce a lower prevalence of MetS than expected. Alternatively, the preven-
tive screening and healthcare may have attracted individuals with existing health concerns 
or those advised to improve their health by family, friends or a medical practitioner. Despite 
such potential biases, the sample means for health indicators such as blood pressure, BMI, 
and the proportion of overweight and obese, are very similar to values from nationally rep-
resentative samples reported as part of UK health surveillance31. 
The use of estimated peak oxygen uptake is also a limitation of the study. There are no ref-
erence data for CRF in UK adults with which to compare the present values. However, the 
estimates of CRF reported here are comparable with studies using expired gas analysis9. 
Age-related cut-offs31 for low fitness are based on values approximating the 20th percentile 
of the reference population, the proportion of men classified as unfit (24.5%) also support 
the validity of our approach6 7. It should also be noted that the association between MetS 
and CRF is not markedly different between studies reporting estimated or measured peak 
oxygen uptake.   
We defined MetS using the criteria developed by the NCEP as opposed to international cri-
teria16, as most studies investigating CRF and MetS have emanated from North America. 
There is relatively high concordance between these criteria when applied in populations 
similar to the present sample 28.  
We also acknowledge the cross-sectional design of the study; thus cause and effect cannot 
be ascertained. Furthermore, we cannot generalise our findings to the female population. 
Finally, we did not adjust for variations in dietary intake or socioeconomic status which may 
have acted to confound the associations.  
 
Conclusion 
The value of assessing CRF in asymptomatic adults is well established, yet CRF remains ab-
sent from UK health surveillance and screening. The negative association between CRF and 
metabolic risk is well established as is the age-related increase in MetS.  
The present study demonstrated the expected increase in MetS prevalence associated with 
advancing age. Across the age-strata studied (20 – 69 years), prevalence was 32 to 53% low-
er in those men with good CRF (“Fit”). The association between CRF and MetS is stronger in 
younger men and, while it weakens with age, the association between CRF and MetS re-
mains independent of BMI for men aged 20-49 years. Public health messages should em-
phasise the importance of improving CRF alongside weight management for enhancing car-
dio-metabolic health. Inclusion of CRF assessments in UK health screening would provide 
greater insight into the metabolic health of asymptomatic men. 
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Table 1. Demographic, anthropometric, and metabolic characteristics of 9 666 British men attending  
preventative health screening between 2000 and 2009. 
Cardiorespiratory Fitness        
Classification  
 All 
(9 666) 
Fit 76.2% 
(7 265) 
 Unfit 24.8%         
(2 401) 
P-value  
 Mean 
or % 
(SD)  Mean 
or % 
(SD)  Mean 
or % 
(SD)  
English Index of Deprivation 10.6 (8.2)  10.6 (8.0)  10.7 (8.6) 0.142 
Age (years) 48.7 (8.4)  49.5 (8.3)  46.6 (8.4) <0.001 
Stature (m) 1.78 (0.66)  1.79 (0.65)  1.79 (0.66) <0.001 
Weight (kg) 86.6 (12.5)  85.6 (11.8)  90.2 (14.0) <0.001 
BMI (kg·m-2) 27.1 (3.5)  26.8 (3.3)  28.2 (3.5) <0.001 
Overweight (%)               54.3   54.9   52.0  0.405* 
Obese (%) 17.8   15.2   16.4  <0.001* 
‡Waist Circumference (cm) 94.3 (10.0)  93.4 (9.5)  97.4 (10.0) <0.001 
VO2peak (ml·kg-1·min-1) 38.7 (9.9)  41.2 (8.0)  28.1 (3.8) <0.001 
Current Smokers (%) 8.6   8.4   9.0  0.103 
‡SBP  (mmHg) 125.7 (12.5)  125.2 (12.5)  127.1 (12.5) <0.001 
‡DBP  (mmHg) 81.2 (8.2)  81.0 (8.1)  82.3 (8.3) <0.001 
‡Fasting Glucose (mmol·l-1) 5.47 (0.74)  5.4 (0.72)  5.5 (0.83) 0.075 
LDL (mmol·l-1) 3.36 (0.86)  3.4 (0.87)  3.4 (0.86) 0.605 
‡HDL (mmol·l-1) 1.40 (0.34)  1.4 (0.34)  1.3 (0.34) <0.001 
‡Triglycerides  (mmol·l-1) 1.46 (0.96)  1.4 (0.91  1.6 (0.96 <0.001 
 
 
Data presented as mean (SD) or %; BMI – Body Mass Index; Overweight BMI 25.0-29.9 kg·m-2; Obese - BMI 
>29.9 kg·m-2.; VO2peak (ml·kg-1·min-1) – peak oxygen consumption during symptom limited treadmill exercise; 
SBP – Systolic Blood Pressure; DBP – Diastolic Blood Pressure. LDL – Low Density Lipoprotein; HDL – High Den-
sity Lipoprotein. ‡-Indicates component of Metabolic Syndrome (MetS). P-values determined from independ-
ent t-test (Fit versus Unfit) or * χ2 test. 
 
 
 
 
 
 
Table 2. Components and prevalence of NCEP ATP III defined metabolic syndrome in 9 666 British men 
                    All           20-39     yrs 40-49 yrs 50-59 yrs 60-69 yrs P-value 
Waist Circumference (%) (>102 
cm) 
50.5 39.1 48.8 54.1 58.4 <0.001 
Blood Pressure (%) 
(>135/80 mmHG) 
47.9 36.1 43.9 53.1 59.9 <0.001 
Plasma Glucose (%) 
(>6.1 mmol·l-1) 
39.4 29.4 37.1 43.8 45.6 <0.001 
Plasma Triglycerides (%)(>1.7 
mmol·l-1)                                            
28.5 26.3 29.7 29.9 21.3 <0.001 
HDL (%) 
(<1.034 mmol·l-1) 
13.5 13.9 14.6 12.6 12.3 0.044 
Prevalence of MetS (%) 25.5% 17.1% 24.1% 28.5% 30.1% <0.001 
 
Legend: HDL – high density lipoprotein; NCEP ATP - National Cholesterol Education Program (NCEP) Expert 
Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) 
P-values correspond to statistical significance for main effect on one-way ANOVA.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Likelihood of the Metabolic Syndrome (NCEP ATP III Criteria) according to cardiorespiratory fit-
ness in 9 666 British men 
  Model 1:  
OR (95%CI) 
P-value Model 2:  
OR (95%CI) 
P-value 
All  
(n=9666) 
Unfit  
Fit 
1.00 
0.51 (0.46-0.57) 
 
<0.001 
1.00  
0.73 (0.65-0.82) 
 
<0.001 
Age 20-39  
Unfit  
Fit 
1.00 
0.46 (0.33-0.62) 
 
<0.001 
1.00 
0.67(0.47-0.97) 
 
<0.001 
Age 40-49  
Unfit  
Fit 
1.00 
0.47 (0.41-0.55) 
 
<0.001 
1.00 
0.66 (0.48-0.78) 
 
<0.001 
Age 50-59  
Unfit  
Fit 
1.00 
0.54 (0.46-0.64) 
 
<0.001 
1.00 
0.83 (0.68-1.02) 
 
 0.072 
Age 60-69 Unfit  
Fit 
1.00 
0.68 (0.48-0.98) 
 
 0.004 
1.00 
0.84 (0.54-1.28) 
 
 0.319 
 
Legend: NCEP ATP III - National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evalua-
tion, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) 
OR = Odds ratio; Fit or Unfit based on estimated VO2peak above or below (respectively) the Cooper Insti-
tute age- and sex-specific cut-offs for poor cardiorespiratory fitness 
 
Model 1. Adjusted for age, smoking status, area level deprivation;  
Model 2. Adjusted for age, smoking status, area level deprivation, and body mass index (kg∙m-2).  
 
